0000897069-14-000317.txt : 20140624 0000897069-14-000317.hdr.sgml : 20140624 20140624132811 ACCESSION NUMBER: 0000897069-14-000317 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140624 DATE AS OF CHANGE: 20140624 EFFECTIVENESS DATE: 20140624 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Romark Laboratories, L.C. CENTRAL INDEX KEY: 0001470263 IRS NUMBER: 593276909 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-219719 FILM NUMBER: 14937072 BUSINESS ADDRESS: STREET 1: 3000 BAYPORT DRIVE STREET 2: SUITE 200 CITY: TAMPA STATE: FL ZIP: 33607 BUSINESS PHONE: 813-282-8544 MAIL ADDRESS: STREET 1: 3000 BAYPORT DRIVE STREET 2: SUITE 200 CITY: TAMPA STATE: FL ZIP: 33607 D 1 primary_doc.xml X0707 D LIVE 0001470263 Romark Laboratories, L.C. 3000 BAYPORT DRIVE SUITE 200 TAMPA FL FLORIDA 33607 813-282-8544 FLORIDA None None Limited Liability Company true Jean Francois Rossignol 3000 Bayport Drive Suite 200 Tampa FL FLORIDA 33607 Executive Officer Director Marc S. Ayers 3000 Bayport Drive Suite 200 Tampa FL FLORIDA 33607 Executive Officer Director Celine E. Rossignol 3000 Bayport Drive Suite 200 Tampa FL FLORIDA 33607 Executive Officer Brian Schnieders 3000 Bayport Drive Suite 200 Tampa FL FLORIDA 33607 Executive Officer W. Seymour Holt 3000 Bayport Drive Suite 200 Tampa FL FLORIDA 33607 Director W. Andrew Krusen, Jr. 3000 Bayport Drive Suite 200 Tampa FL FLORIDA 33607 Director Kurt Frahn 3000 Bayport Drive Suite 200 Tampa FL FLORIDA 33607 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2014-05-27 false true true true false 100000 International Assets Advisory, LLC 10645 None None 300 South Orange Avenue Suite 1100 Orlando FL FLORIDA 32801 All States false Source Capital Group, Inc. 36719 None None 276 Post Road West Westport CT CONNECTICUT 06880 All States false WFG Investments, Inc. 22704 None None 2711 N. Haskell Avenue Suite 2900 Dallas TX TEXAS 75204 RI RHODE ISLAND VT VERMONT HI HAWAII VA VIRGINIA MI MICHIGAN DE DELAWARE ID IDAHO IA IOWA MD MARYLAND MA MASSACHUSETTS AR ARKANSAS IL ILLINOIS UT UTAH IN INDIANA MN MINNESOTA AZ ARIZONA MO MISSOURI MT MONTANA MS MISSISSIPPI NH NEW HAMPSHIRE NJ NEW JERSEY NM NEW MEXICO AK ALASKA TX TEXAS AL ALABAMA NC NORTH CAROLINA ND NORTH DAKOTA NE NEBRASKA NY NEW YORK GA GEORGIA NV NEVADA TN TENNESSEE CA CALIFORNIA OK OKLAHOMA OH OHIO WY WYOMING FL FLORIDA SD SOUTH DAKOTA SC SOUTH CAROLINA CT CONNECTICUT WV WEST VIRGINIA DC DISTRICT OF COLUMBIA KY KENTUCKY WI WISCONSIN KS KANSAS OR OREGON LA LOUISIANA WA WASHINGTON CO COLORADO PA PENNSYLVANIA false 10000000 1914850 8085150 false 19 1000000 true 0 10% of the gross proceeds raised, a non-accountable expense allowance in an amount equal to 1.0% of gross proceeds, reimbursement of reasonable out-of-pocket expenses and a Warrant to purchase Common Units equal to 15% of the number of Class C Units issue 0 false Romark Laboratories, L.C. Kurt Frahn Kurt Frahn Chief Financial Officer 2014-06-23